Dr. Asnat Raziel

My articles

My articles

Weight regain after bariatric surgery: can Ozempic or Wegovy restart weight loss?

Weight regain after bariatric surgery: when weight loss stalls

Weight regain after bariatric surgery is a well-known phenomenon, and it is not a personal failure. However effective an operation is, it is not always the end of the road. In some patients, weight loss stops earlier than expected. In others, some of the weight returns months or years later. The good news is that GLP-1 injections, such as semaglutide in Ozempic and Wegovy, can get weight loss moving again.

According to a study from Hamburg, about 20% to 25% of patients experience regain or insufficient weight loss. That is why it helps to know that good tools now exist for this stage. You can read more about the specific situation after a sleeve in my article on weight regain after sleeve gastrectomy.

Why does weight regain after bariatric surgery happen?

The causes span several areas. First, there are behavioral factors: a return to old eating patterns and less physical activity. Second, there are emotional factors, such as emotional eating and stress. In addition, the body adapts metabolically to weight loss. Sometimes the anatomy changes too, for example when the remaining stomach stretches. Finally, other medications, hormonal changes during menopause and long periods of stress also affect weight.

It is important to understand that obesity is a chronic disease. Surgery changes your biology profoundly, but it does not “cure” obesity forever. Therefore, regular follow-up after surgery lets us spot a trend early and respond before the kilograms add up. I also wrote about this in my article on obesity as a chronic disease.

The role of the GLP-1 hormone

Operations such as the sleeve gastrectomy and gastric bypass sharply raise GLP-1 levels after meals. This is one of the main mechanisms behind weight loss and the feeling of fullness. Even so, not every patient responds with the same strength. A review in the International Journal of Obesity described a link between a strong GLP-1 response after meals and successful weight loss. In other words, people who regain weight often have a weaker hormonal response.

What studies show about weight regain after bariatric surgery

In the Hamburg study, doctors treated 44 patients without diabetes with semaglutide. After 3 months, they had lost an average of 6.0% of their weight. After 6 months, the loss reached 10.3%. Later, a one-year follow-up of 29 patients showed an average loss of 14.7%.

Similarly, a Swiss study included 50 patients treated with liraglutide or semaglutide. After 6 months, they had lost 8.8% of their weight. In other words, they shed about two-thirds of the weight they had regained after surgery. In addition, the researchers reported no serious side effects.

That said, these are observational studies. A 2024 systematic review pooled 10 studies with 594 patients. Weight loss ranged from 5% to 17% over 6 to 12 months. On the other hand, 10% to 50% of patients reported non-serious side effects, mainly nausea.

The first randomized trial

Important support came in 2025. A double-blind randomized trial from Australia included 48 patients who had responded only partially to surgery. After 12 months, the liraglutide group had lost an average of 5.7 kg. By contrast, the placebo group gained 1.4 kg. The gap between the groups was 7.1 kg.

Tirzepatide after surgery: the new data

In the past, we estimated that tirzepatide, the active ingredient in Mounjaro, might offer an advantage. Today we have data to support this. A nationwide US study looked at 208,155 patients who had bariatric surgery, of whom 39,750 received a medication afterward. Among those who stayed on treatment for a year, tirzepatide led to a loss of 17.2%, compared with 12.0% with semaglutide. Interestingly, a late start, between months 53 and 79 after surgery, led to a loss of 15.4%, compared with 13.5% with an early start. You will find more about this drug on my Mounjaro page.

Weight regain after bariatric surgery: medication or another operation?

Medications are not always a full substitute for revisional surgery. A multicenter study compared 4,901 patients after a sleeve. Those who were converted to a gastric bypass lost 26.1% of their weight after 3 years. In comparison, those treated with medication lost 13.7%. So the decision is personal, based on the medical situation, the anatomy and the patient’s preferences.

On one hand, revisional surgery usually brings greater weight loss. On the other hand, it carries surgical risk and requires recovery. For many people, medication for weight regain after bariatric surgery is a reasonable first step, and surgery can be considered later. For a broad look at the options, see my guide to alternatives to bariatric surgery.

Why the injections work even after surgery

The physiological logic is clear. Unlike pills, the injections do not depend on absorption through the digestive tract. Instead, they act in the brain: they reduce hunger, cravings and “food noise,” the intrusive thoughts about food. They also slow stomach emptying and help balance blood sugar. Surgery changes the anatomy, but it does not cancel out these pathways. I wrote about this phenomenon in detail in my article on food noise.

However, the effect is not always noticeable right away. In the early period after surgery, eating is already very limited, so the drug’s contribution is less obvious. In other situations, unrealistic expectations, soft and sweet foods, poor sleep or a dose that is too low can blur the effect.

Treating weight regain after bariatric surgery: what we check

When a patient who has had surgery does not respond to medication, we do a comprehensive assessment. It includes:

  • Reviewing the dose and how quickly it was increased.
  • Checking adherence and correct injection technique.
  • Identifying problematic eating patterns, such as constant grazing.
  • Ruling out medical causes, for example an underactive thyroid or weight-promoting medications.
  • Sometimes an anatomical evaluation as well, to rule out a stretched pouch or another surgical problem.

At the same time, your diet should be rich in protein and low in simple sugars. Tailored physical activity and good-quality sleep also support treatment. You will find practical advice in my nutrition guide for weight loss injections.

The bottom line

Weight regain after bariatric surgery is not the end of the story. Evidence for GLP-1 medications in this situation keeps growing, and we now have a randomized trial and data on tirzepatide as well. Still, the drug does not replace surgery. Rather, it is a natural extension of the view that obesity is a chronic disease. Ultimately, success comes from combining surgical, medical and behavioral tools, with long-term support from an expert team.

The information in this article is general and does not replace personal medical advice.

References

The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery – a Retrospective Analysis

Sustained weight loss with semaglutide once weekly in patients without type 2 diabetes and post-bariatric treatment failure

Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study

Adjuvant Glucose-Like Peptide 1 Receptor Agonist Therapy for Suboptimal Weight Loss After Bariatric Surgery: a Systematic Review

Liraglutide and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery: A Randomized Clinical Trial

Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels

Weight loss and cardiovascular outcomes with incretin-based therapies after metabolic and bariatric surgery: a nationwide US cohort study

Sleeve-to-bypass conversion vs. sleeve-with-adjuvant GLP-1 receptor agonists: an academic multicenter retrospective study

Weight regain after bariatric surgery - GLP-1 injection treatment after a sleeve or gastric bypass

ד”ר אסנת רזיאל